RVX.TO
Resverlogix Corp
Price:  
0.10 
CAD
Volume:  
1,008.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVX.TO Relative Valuation

-134.8%
Upside

As of 2026-01-05, the Relative Valuation of Resverlogix Corp (RVX.TO) is (0.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of Resverlogix Corp based on Relative Valuation is -134.8%.

The range of the Relative Valuation is (0.05) - (0.03) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 1.4x - 2.1x 1.8x
Forward P/E multiples -0.3x - 0.9x 0.3x
Fair Price (0.05) - (0.03) (0.03)
Upside -147.5% - -131.9% -134.8%
0.10 CAD
Stock Price
(0.03) CAD
Fair Price

RVX.TO Relative Valuation - Historical P/E Data

Date P/E
2026-01-02 -2.95
2025-12-31 -2.95
2025-12-30 -2.80
2025-12-29 -2.80
2025-12-24 -2.65
2025-12-23 -2.80
2025-12-22 -2.95
2025-12-19 -2.80
2025-12-18 -3.10
2025-12-17 -3.24
2025-12-16 -3.24
2025-12-15 -3.10
2025-12-12 -3.24
2025-12-11 -3.39
2025-12-10 -3.39
2025-12-09 -3.54
2025-12-08 -3.54
2025-12-05 -3.39
2025-12-04 -3.69
2025-12-03 -3.98
2025-12-02 -4.13
2025-12-01 -3.54
2025-11-28 -3.24
2025-11-26 -3.24
2025-11-25 -2.95
2025-11-24 -3.24
2025-11-21 -3.39
2025-11-20 -3.10
2025-11-19 -3.10
2025-11-18 -2.95
2025-11-17 -2.95
2025-11-13 -2.95
2025-11-12 -2.80
2025-11-11 -2.95
2025-11-10 -2.95
2025-11-07 -2.80
2025-11-05 -2.80
2025-11-04 -2.95
2025-11-03 -2.80
2025-10-31 -2.80
2025-10-30 -2.65
2025-10-29 -2.95
2025-10-28 -2.80
2025-10-27 -2.95
2025-10-24 -2.80
2025-10-23 -2.80
2025-10-22 -2.95
2025-10-21 -3.10
2025-10-20 -3.10
2025-10-17 -3.10